CB MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CB MEDICAL
Largest movements
- Tangible fixed assets +€138,963
up €138,963 (+11.7%), from €1.2m to €1.3m
of which Plant, machinery and equipment: +€79,295
- Reserves +€116,669
up €116,669 (+8.4%), from €1.4m to €1.5m
of which Distributable reserves: +€116,669
- Debts after one year -€32,691
no longer reported in 2025 (was €32,691)
- Tax, wage and social debts +€28,232
up €28,232 (+96.6%), from €29,213 to €57,445
of which Taxes: +€25,475
- Gross operating margin +€82,460
up €82,460 (+15.7%), from €526,357 to €608,816
- Taxes +€26,301
up €26,301 (+24.6%), from €106,713 to €133,013
- Financial charges -€21,627
down €21,627 (-25.8%), from €83,699 to €62,072
- Staff costs +€10,837
new in 2025: €10,837
- Depreciation +€6,552
up €6,552 (+6.2%), from €105,938 to €112,490
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,777,826 | €1,898,195 | +€120,369 | +6.8% |
| Fixed assets | 21/28 | €1,184,275 | €1,323,238 | +€138,963 | +11.7% |
| Tangible fixed assets | 22/27 | €1,184,275 | €1,323,238 | +€138,963 | +11.7% |
| Land and buildings | 22 | €1,111,576 | €1,110,920 | -€656 | -0.1% |
| Plant, machinery and equipment | 23 | €20,872 | €100,167 | +€79,295 | +380% |
| Furniture and vehicles | 24 | €51,828 | €104,451 | +€52,623 | +102% |
| Assets under construction and advance payments | 27 | - | €7,700 | +€7,700 | |
| Current assets | 29/58 | €593,551 | €574,957 | -€18,594 | -3.1% |
| Amounts receivable within one year | 40/41 | €20,125 | €2,420 | -€17,706 | -88.0% |
| Other amounts receivable | 41 | €20,125 | €2,420 | -€17,706 | -88.0% |
| Cash at bank and in hand | 54/58 | €443,130 | €424,926 | -€18,204 | -4.1% |
| Deferred charges and accrued income | 490/1 | €130,296 | €147,612 | +€17,316 | +13.3% |
| Total equity and liabilities | 10/49 | €1,777,826 | €1,898,195 | +€120,369 | +6.8% |
| Equity | 10/15 | €1,646,721 | €1,763,391 | +€116,669 | +7.1% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Capital | 10 | €6,200 | €6,200 | = | 0.0% |
| Issued capital | 100 | €19,000 | €19,000 | = | 0.0% |
| Uncalled capital | 101 | €12,800 | €12,800 | = | 0.0% |
| Reserves | 13 | €1,396,071 | €1,512,740 | +€116,669 | +8.4% |
| Non-distributable reserves | 130/1 | €1,900 | €1,900 | = | 0.0% |
| Legal reserve | 130 | €1,900 | €1,900 | = | 0.0% |
| Tax-exempt reserves | 132 | €2,185 | €2,185 | = | 0.0% |
| Distributable reserves | 133 | €1,391,986 | €1,508,655 | +€116,669 | +8.4% |
| Profit (loss) carried forward | 14 | €244,451 | €244,451 | = | 0.0% |
| Amounts payable | 17/49 | €131,105 | €134,805 | +€3,700 | +2.8% |
| Amounts payable after more than one year | 17 | €32,691 | - | -€32,691 | |
| Financial debts | 170/4 | €32,691 | - | -€32,691 | |
| Amounts payable within one year | 42/48 | €95,822 | €134,681 | +€38,859 | +40.6% |
| Current portion of amounts payable after more than one year | 42 | €62,240 | €63,035 | +€795 | +1.3% |
| Trade debts | 44 | €4,370 | €14,201 | +€9,832 | +225% |
| Suppliers | 440/4 | €4,370 | €14,201 | +€9,832 | +225% |
| Taxes, remuneration and social security | 45 | €29,213 | €57,445 | +€28,232 | +96.6% |
| Taxes | 450/3 | €29,213 | €54,687 | +€25,475 | +87.2% |
| Remuneration and social security | 454/9 | - | €2,757 | +€2,757 | |
| Accrued charges and deferred income | 492/3 | €2,591 | €124 | -€2,468 | -95.2% |
| Non-recurring operating income | 76A | €1,234 | €10,000 | +€8,766 | +710% |
| Remuneration, social security and pensions | 62 | - | €10,837 | +€10,837 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €105,938 | €112,490 | +€6,552 | +6.2% |
| Other operating charges | 640/8 | €8,477 | €12,788 | +€4,311 | +50.9% |
| Gross operating margin | 9900 | €526,357 | €608,816 | +€82,460 | +15.7% |
| Operating profit (loss) | 9901 | €411,941 | €472,701 | +€60,760 | +14.7% |
| Financial income | 75/76B | €5,307 | €3,723 | -€1,583 | -29.8% |
| Recurring financial income | 75 | €3,873 | €3,723 | -€150 | -3.9% |
| Non-recurring financial income | 76B | €1,434 | - | -€1,434 | |
| Financial charges | 65/66B | €83,699 | €62,072 | -€21,627 | -25.8% |
| Recurring financial charges | 65 | €83,699 | €62,072 | -€21,627 | -25.8% |
| Profit (loss) for the period before taxes | 9903 | €333,549 | €414,352 | +€80,803 | +24.2% |
| Income taxes | 67/77 | €106,713 | €133,013 | +€26,301 | +24.6% |
| Profit (loss) for the period | 9904 | €226,836 | €281,339 | +€54,502 | +24.0% |
| Profit (loss) for the period to be appropriated | 9905 | €226,836 | €281,339 | +€54,502 | +24.0% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.